<PAGE> 1
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(b) OF THE SECURITIES
EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 16, 2000
Commission file number 1-10629
-------
LASER VISION CENTERS, INC.
--------------------------
(Exact name of registrant as specified in its charter)
Delaware 43-1530063
-------- ----------
(State or other jurisdiction of incorporation (I.R.S. Employer identification
or organization) number)
540 Maryville Centre Dr., Suite 200, St. Louis, Missouri 63141
--------------------------------------------------------------
(Address of principal executive offices)
(314) 434-6900
--------------
(Registrant's telephone number, including area code)
<PAGE> 2
FORM 8-K
ITEM 5. OTHER EVENTS
On March 16, 2000, the Company announced that its Board of Directors
approved a share repurchase program of up to five percent (5%) of the Company's
common stock.
On March 16, 2000, the Company issued a press release pertaining to
these matters; a copy of that press release is attached hereto as an exhibit.
ITEM 7( c). LIST OF EXHIBITS FILED
99.1 Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LASER VISION CENTERS, INC.
BY: /s/ John J. Klobnak
-------------------------------
John J. Klobnak
Chief Executive Officer
Date: March 22, 2000
<PAGE> 1
LASERVISION ANNOUNCES
SHARE REPURCHASE PROGRAM
ST. LOUIS, MISSOURI--March 16, 2000--LASER VISION CENTERS, INC., (Nasdaq: LVCI)
announced today that its Board of Directors has authorized a share repurchase
program of up to five percent (5%) of the Company's common stock.
LaserVision expects the approved repurchases to be effected from time to time in
the open market in privately negotiated transactions, or otherwise, subject to
the market price of the common stock and overall market conditions. The purpose
of the repurchase plan is to meet the Company's obligations under its stock
option plans and other stock-based plans, while minimizing dilution to
shareholders.
LaserVision is one of the world's largest providers of excimer lasers, related
equipment and support services for the treatment of nearsightedness,
farsightedness and astigmatism.
Except for historical information, statements relating to the Company's plan,
objectives and future performance are forward looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such statements
are based on management's current expectations. Because of various risks and
uncertainties, actual strategies and results in future periods may differ
materially from those currently expected. Additional discussion of factors
affecting the Company's business is contained in the Company's most recent
filings with the Securities and Exchange Commission.
###
Contact: John A. Stiles
314-434-6900
[email protected]
http://www.laservision.com
